|Articles|July 15, 2003

Allergan wins approval for post-surgical drops

Irvine, CA-Allergan Inc. plans to launch its ketorolac tromethamine ophthalmic solution 0.4% (Acular LS) this summer for the reduction of ocular pain and burning and stinging following corneal refractive surgery.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME